Mark Waskiewicz

Executive Level Vaccines/Biologics CMC Strategy Expert | Integrating Technical Development and Commercialization Strategy with Clinical, Commercial, and Regulatory Requirements

Role
Development and Commercialization Leader at Merck
Location
Norristown, PA, US
LinkedIn followers
500 followers

About Mark Waskiewicz

Seasoned head of CMC strategy development, regulatory submissions oversight, and project management with 30 years of experience on complex biological products and vaccines. Proven track record in leading both regulatory and CMC operations teams, developing and executing successful CMC strategies for global submissions in all development phases (IND, CTA, BLA, MAA, post-approval). Expertise in navigating complex regulatory landscapes and ensuring compliance with global regulations. Proven ability to establish cross-functional teams and procedures for CMC development, cultivating strong relationships with internal and external stakeholders, including regulatory agency staff. Adept at analyzing technical information, identifying gaps, and implementing improvements that support global submissions, enhance efficiency, and achieve organizational goals.

Experience

  1. Development and Commercialization Leader

    Merck

    Jan 2025 — Present · West Point, PA, US

    Responsible for end-to-end technical product leadership of CMC teams and delivery of a fully integrated development and commercialization strategy and timeline to ensure successful launch and long-term supply of biological/vaccine products. Identify, manage, and communicate risks on the programs. Ensure robust process and analytics, integrated control strategy, compliant regulatory submissions, and robust supply chain.

Education

  • Rutgers University

    MS, Biochemical Toxicology

  • University of the Sciences in Philadelphia

    BS, Pharmacology & Toxicology

  • Rutgers Robert Wood Johnson Medical School

    MS, Biochemical Toxicology

Skills

  • Analytical Chemistry
  • Strategy
  • Therapeutic Areas
  • Biologics
  • Change Control
  • Biotechnology
  • Glp
  • Cmc
  • Regulatory Affairs
  • Drug Development
  • Biopharmaceuticals
  • Cmc Regulatory Affairs
  • Toxicology
  • Regulatory Submissions
  • Fda
  • Quality System
  • Quality Systems
  • Vaccines
  • Validation
  • U.s. Food and Drug Administration (Fda)
  • Regulatory Requirements
  • Ind
  • Regulatory Strategy

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Mark Waskiewicz — Development and Commercialization Leader at Merck in Norristown, PA, US | Unifers